Track the Belite Bio, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.1bn. The latest transaction was disclosed on 12 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Dr. Hendrick P. Scholl. All data is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Belite Bio, Inc. Strong Buy (bullish), based on 8 analysts. Average price target: US$214.00.
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.